New Apoptosis Data Have Been Reported by Researchers at University of Pretoria (Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell Line).

Researchers at the University of Pretoria conducted a study on the multi-target inhibitor CUDC-101 and its effects on DNA damage repair and radiation response in triple-negative breast cancer cell lines. The study found that CUDC-101 enhanced radiation response in both proton and X-ray irradiation, particularly in the MDA-MB-231 cell line. The research suggests that CUDC-101 shows promise in the management of triple-negative breast cancer, either as a standalone treatment or in combination with radiation therapy. [Extracted from the article]